M.M. Kockx, M. McCleland, H. Koeppen, Microenvironmental regulation of tumour immunity and response to immunotherapy. J. Pathol. 254(4), 374–383 (2021). https://doi.org/10.1002/path.5681

Article  PubMed  PubMed Central  Google Scholar 

J. Galon, A. Costes, F. Sanchez-Cabo et al., Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 313(5795), 1960–1964 (2006). https://doi.org/10.1126/science.1129139

Article  CAS  PubMed  Google Scholar 

M. Backman, C. Strell, A. Lindberg et al., Spatial immunophenotyping of the tumour microenvironment in non–small cell lung cancer. Eur. J. Cancer. 185, 40–52 (2023). https://doi.org/10.1016/j.ejca.2023.02.012

Article  CAS  PubMed  Google Scholar 

P. Rocha, M. Rodrigo, L. Moliner et al., Pre-existing tumor host immunity characterization in resected non-small cell lung cancer. Lung Cancer. 181, 107257 (2023). https://doi.org/10.1016/j.lungcan.2023.107257

Article  CAS  PubMed  Google Scholar 

K.I. Al-Shibli, T. Donnem, S. Al-Saad, M. Persson, R.M. Bremnes, L.T. Busund, Prognostic effect of epithelial and stromal lymphocyte infiltration in Non–Small cell lung Cancer. Clin. Cancer Res. 14(16), 5220–5227 (2008). https://doi.org/10.1158/1078-0432.CCR-08-0133

Article  CAS  PubMed  Google Scholar 

J. Galon, B. Mlecnik, G. Bindea et al., Towards the introduction of the ‘immunoscore’ in the classification of malignant tumours. J. Pathol. 232(2), 199–209 (2014). https://doi.org/10.1002/path.4287

Article  CAS  PubMed  Google Scholar 

R.M. Bremnes, L.T. Busund, T.L. Kilvær et al., The role of Tumor-Infiltrating lymphocytes in development, progression, and prognosis of Non–Small cell lung Cancer. J. Thorac. Oncol. 11(6), 789–800 (2016). https://doi.org/10.1016/j.jtho.2016.01.015

Article  PubMed  Google Scholar 

A. Mezheyeuski, C.H. Bergsland, M. Backman et al., Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients. J. Pathol. 244(4), 421–431 (2018). https://doi.org/10.1002/path.5026

Article  CAS  PubMed  Google Scholar 

K. Hiraoka, M. Miyamoto, Y. Cho et al., Concurrent infiltration by CD8 + T cells and CD4 + T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br. J. Cancer. 94(2), 275–280 (2006). https://doi.org/10.1038/sj.bjc.6602934

Article  CAS  PubMed  PubMed Central  Google Scholar 

S.K. Johnson, K.M. Kerr, A.D. Chapman et al., Immune cell infiltrates and prognosis in primary carcinoma of the lung. Lung Cancer. 27(1), 27–35 (2000). https://doi.org/10.1016/S0169-5002(99)00095-1

Article  CAS  PubMed  Google Scholar 

S. Mao, Y. Wang, N. Chao, L. Zeng, L. Zhang, Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma. Cell. Oncol. 47(5), 1697–1713 (2024). https://doi.org/10.1007/s13402-024-00948-4

Article  CAS  Google Scholar 

M. Schmidt, B. Hellwig, S. Hammad et al., A comprehensive analysis of human gene expression profiles identifies stromal Immunoglobulin Κ C as a compatible prognostic marker in human solid tumors. Clin. Cancer Res. 18(9), 2695–2703 (2012). https://doi.org/10.1158/1078-0432.CCR-11-2210

Article  CAS  PubMed  Google Scholar 

M. Lohr, K. Edlund, J. Botling et al., The prognostic relevance of tumour-infiltrating plasma cells and Immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer. Cancer Lett. 333(2), 222–228 (2013). https://doi.org/10.1016/j.canlet.2013.01.036

Article  CAS  PubMed  Google Scholar 

M. Backman, La L. Fleur, P. Kurppa et al., Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer. J. Pathol. 255(3), 243–256 (2021). https://doi.org/10.1002/path.5772

Article  CAS  PubMed  Google Scholar 

L. Shu, J. Tang, S. Liu, Y. Tao, Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma. Cell. Oncol. 47(2), 555–571 (2024). https://doi.org/10.1007/s13402-023-00883-w

Article  CAS  Google Scholar 

S. Barua, P. Fang, A. Sharma et al., Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer. Lung Cancer. 117, 73–79 (2018). https://doi.org/10.1016/j.lungcan.2018.01.022

Article  PubMed  Google Scholar 

Z. Li, D. Maeda, M. Yoshida et al., The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer. Lung Cancer. 123, 127–135 (2018). https://doi.org/10.1016/j.lungcan.2018.07.015

Article  PubMed  Google Scholar 

K.A. Schalper, J. Brown, D. Carvajal-Hausdorf et al., Objective measurement and clinical significance of TILs in Non–Small cell lung Cancer. J. Natl. Cancer Inst. 107(3), dju435 (2015). https://doi.org/10.1093/jnci/dju435

Article  CAS  PubMed  PubMed Central  Google Scholar 

A. Sandström Gerdtsson, M. Knulst, J. Botling, A. Mezheyeuski, P. Micke, S. Ek, Phenotypic characterization of Spatial immune infiltration niches in non-small cell lung cancer. Oncoimmunology 12(1):2206725. https://doi.org/10.1080/2162402X.2023.2206725

K. Isomoto, K. Haratani, T. Tsujikawa et al., Mechanisms of primary and acquired resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer: A multiplex immunohistochemistry-based single-cell analysis. Lung Cancer. 174, 71–82 (2022). https://doi.org/10.1016/j.lungcan.2022.10.012

Article  CAS  PubMed  Google Scholar 

I. Gataa, L. Mezquita, C. Rossoni et al., Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non–small cell lung cancer treated with immunotherapy. Eur. J. Cancer. 145, 221–229 (2021). https://doi.org/10.1016/j.ejca.2020.10.017

Article  CAS  PubMed  Google Scholar 

D.B. Page, G. Broeckx, C.A. Jahangir et al., Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the international Immuno-Oncology biomarker working group on breast Cancer. J. Pathol. 260(5), 514–532 (2023). https://doi.org/10.1002/path.6165

Article  CAS  PubMed  PubMed Central  Google Scholar 

T. Cupedo, R.E. Mebius, Role of chemokines in the development of secondary and tertiary lymphoid tissues. Sem Immunol. 15(5), 243–248 (2003). https://doi.org/10.1016/j.smim.2003.08.002

Article  CAS  Google Scholar 

K.G. McDonald, J.S. McDonough, R.D. Newberry, Adaptive immune responses are dispensable for isolated lymphoid follicle formation: Antigen-Naive, Lymphotoxin-Sufficient B lymphocytes drive the formation of mature isolated lymphoid follicles. J. Immunol. 174(9), 5720–5728 (2005). https://doi.org/10.4049/jimmunol.174.9.5720

Article  CAS  PubMed  Google Scholar 

N. Jacquelot, J. Tellier, S. Nutt, G. Belz, Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies. Oncoimmunology 10(1). https://doi.org/10.1080/2162402X.2021.1900508

X. Chen, P. Wu, Z. Liu et al., Tertiary lymphoid structures and their therapeutic implications in cancer. Cell. Oncol. 47(5), 1579–1592 (2024). https://doi.org/10.1007/s13402-024-00975-1

Article  Google Scholar 

M.C. Dieu-Nosjean, M. Antoine, C. Danel et al., Long-Term survival for patients with Non–Small-Cell lung Cancer with intratumoral lymphoid structures. J. Clin. Oncol. 2008(26):4410–4417. https://doi.org/10.1200/JCO.2007.15.0284

Y. Tamiya, T. Nakai, A. Suzuki et al., The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinoma. Lung Cancer. 174, 125–132 (2022). https://doi.org/10.1016/j.lungcan.2022.11.001

Article  PubMed  Google Scholar 

J. Gong, D. Yu, Mapping the immune terrain in lung adenocarcinoma progression: Tfh-like cells in tertiary lymphoid structures. Cell. Oncol. 47(4), 1493–1496 (2024). https://doi.org/10.1007/s13402-024-00936-8

Article  Google Scholar 

de L. Chaisemartin, J. Goc, D. Damotte et al., Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung Cancer. Cancer Res. 71(20), 6391–6399 (2011). https://doi.org/10.1158/0008-5472.CAN-11-0952

Article  CAS  PubMed  Google Scholar 

C. Germain, S. Gnjatic, F. Tamzalit et al., Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung Cancer. Am. J. Respir Crit. Care Med. 189(7), 832–844 (2014).